Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05656924 · ClinicalTrials.gov registry record · Phase 2

Deploying Digital Prosthetic Interface Technology and Exercise in Dysvascular Amputees

A Phase 2 study of Amputation and Diabete Type 2, sponsored by Spaulding Rehabilitation Hospital.

Recruiting
Registry status
Phase 2
Development phase
38
Enrollment target
1
Study location

NCT05656924 is a Phase 2 study of Amputation and Diabete Type 2 that is actively recruiting participants, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 38 participants, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05656924, a Phase 2 study of Amputation and Diabete Type 2, is actively recruiting participants, sponsored by Spaulding Rehabilitation Hospital.

RECRUITING
Registry status
Phase 2
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

The study will test a new approach to the design and implementation of socket and liner technology in individuals who lost a lower limb secondary to diabetes mellitus type II (herein referred to as dysvascular amputees). The technology-based intervention will be combined with an exercise program designed to improve the health status of dysvascular amputees.

Interventions

  • DEVICE digital prosthetic interface technology

Study Locations (1)

Massachusetts

  • Spaulding Rehabilitation Hospital Boston - Boston

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2023-12-20
Est. Completion 2026-12-31
Phase Phase 2

Sponsor

Spaulding Rehabilitation Hospital

101 total trials

What the Registry Record Tells You About NCT05656924

The ClinicalTrials.gov registry entry for NCT05656924 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (71% lower). The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Amputation appearing as the primary indexed condition, and to 1 intervention - of which digital prosthetic interface technology is the first listed.

NCT05656924 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05656924 about?

NCT05656924 is a clinical study titled "Deploying Digital Prosthetic Interface Technology and Exercise in Dysvascular Amputees". The study will test a new approach to the design and implementation of socket and liner technology in individuals who lost a lower limb secondary to diabetes mellitus type II (herein referred to as dysvascular amputees). The technology-based intervention will be combined with an exercise program des...

What is the current status of trial NCT05656924?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 2023-12-20. Estimated completion is 2026-12-31.

What conditions does trial NCT05656924 study?

This clinical trial studies the following conditions: Amputation, Diabete Type 2.

What interventions are being tested in trial NCT05656924?

The interventions under investigation include: digital prosthetic interface technology (DEVICE).

Who is sponsoring clinical trial NCT05656924?

This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05656924 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.